Cortical superficial siderosis progression as a biomarker for cerebral amyloid angiopathy.


  • Analyzing cortical superficial siderosis (cSS) in patients suffering from cerebral amyloid angiopathy (CAA) may help health care professionals more accurately diagnosis disease severity and assess risk.

Why this matters

    Identifying clinical biomarkers for CAA, a major predictor for cognitive decline and dementia, is essential to properly care for and treat patients suffering from this disease.